2 results

• Limbrel Recall Issued Over Liver Injury Risks

  January 31, 2018

  Irvin Jackson

  A Limbrel recall comes about a month after the FDA began pressuring Primus Pharmaceuticals to remove the osteoarthritis medical food products from the market following reports of liver injury and hypersensitivity.

• Limbrel Side Effects Linked To Liver Injury Risks, FDA Warns

  December 6, 2017

  Irvin Jackson

  The FDA is urging consumers not to use Limbrel, capsules marketed as medical food for the treatment of osteoarthritis, due to liver and hypersensitivity risks. It has also called for a Limbrel recall, but the manufacturer has so far refused to comply.